Investors: Alven, daphni, Teampact.ventures, Galion.exe, VIVES Partners
Paris-based biotech startup using AI to discover novel molecules from microbial DNA raised €20M Series A to scale drug discovery and develop new antibiotics.
Investors: Alven, Daphni, Galion.exe, Teampact Ventures, VIVES Partners
<cite index="51-1">Paris-based biotech startup Generare raising €20 million in Series A funding to increase its drug discovery compound library by generating novel, high-quality molecular data for drug development by decoding microbial genomes.</cite>